# BUDESONIDE
> **ANDA205710** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2017-11-16
## Drug
- **FDA Application Number:** ANDA205710
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUDESONIDE
- **Generic name:** BUDESONIDE
- **Active ingredients:** BUDESONIDE
- **Dosage form:** SUSPENSION
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2017-11-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205710)
---
*AI Analytics · CC0 1.0*